The stock of Biocept Inc. (BIOC) has seen a -21.15% decrease in the past week, with a -47.06% drop in the past month, and a -72.10% decrease in the past quarter. The volatility ratio for the week is 61.20%, and the volatility levels for the past 30 days are at 20.83% for BIOC. The simple moving average for the past 20 days is -40.60% for BIOC’s stock, with a -77.22% simple moving average for the past 200 days.
Is It Worth Investing in Biocept Inc. (NASDAQ: BIOC) Right Now?
and a 36-month beta value of 0.94. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
The average price predicted for Biocept Inc. (BIOC) by analysts is $330.00, which is -$0.25 below the current market price. The public float for BIOC is 0.59M, and at present, short sellers hold a 1.73% of that float. On May 25, 2023, the average trading volume of BIOC was 102.41K shares.
BIOC) stock’s latest price update
Biocept Inc. (NASDAQ: BIOC)’s stock price has gone decline by -18.11 in comparison to its previous close of 5.19, however, the company has experienced a -21.15% decrease in its stock price over the last five trading days.
BIOC Trading at -51.35% from the 50-Day Moving Average
After a stumble in the market that brought BIOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.09% of loss for the given period.
Volatility was left at 20.83%, however, over the last 30 days, the volatility rate increased by 61.20%, as shares sank -48.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -61.87% lower at present.
During the last 5 trading sessions, BIOC fell by -21.15%, which changed the moving average for the period of 200-days by -87.00% in comparison to the 20-day moving average, which settled at $6.96. In addition, Biocept Inc. saw -73.27% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIOC
Current profitability levels for the company are sitting at:
- -123.69 for the present operating margin
- -9.99 for the gross margin
The net margin for Biocept Inc. stands at -124.09.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.97.
To sum up, Biocept Inc. (BIOC) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.